About PubGene, Inc.

PubGene, Inc. was formed in response to a clear demand for products that organize information for life-sciences. The body of scientific literature increases at a dizzying rate. The sheer mass of information cries out for solutions that gather related information and juxtapose concepts - allowing the investigator to visualize and quickly navigate published results and relate these to their ongoing studies.

Information relevant to drug development, disease prevention, diagnostics and other issues pertaining to human health and well being is the data-domain that PubGene addresses. Our current products have been developed from a gene-centric perspective: PubGene users search our databases with gene names to display "bubble maps" (networks) that represent relationships between genes. Other terms - "keywords" - can also be used to retrieve networks of genes (learn more through our tutorials).

No where is the need for these "bioinformatic" solutions more evident than in the field of gene analysis using microarrays. Studies using microarrays examine gene behavior in tens of thousands of genes simultaneously. The technique is now widely used in research and development at major pharmaceutical companies and is a big part of ongoing research at public institutions. Revenues to suppliers of microarray related materials are on the scale of many $100 million.

PubGene, Inc. is a privately held US-based bioinformatics company. PubGene, Inc. wholly owns its Norwegian subsidiary PubGene AS, where most of product development and coordination of marketing activities are carried out. PubGene is a member of the Oslo Cancer Cluster and is a client of Innovation Norway.